about
Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune responseTumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1MFG-E8 regulates the immunogenic potential of dendritic cells primed with necrotic cell-mediated inflammatory signalsInduction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival.Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.The impact of the TIM gene family on tumor immunity and immunosuppression.Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.Regulation of cancer stem cell activities by tumor-associated macrophagesInterleukin 34, from pathogenesis to clinical applications.TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report.Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphomaInterleukin-34, a comprehensive review
P50
Q26863081-BEF0F1A3-19EF-4ABC-8DFE-B4B948998B58Q28116224-6EC2EF99-F3DA-465E-83EE-5E78D115D1EDQ34326315-0B87EBBD-4750-4C07-8620-B091F07D980EQ34428845-AAC34DE7-9934-40D5-B38E-A4BA6203B36BQ37021675-84A5069A-EE5A-4263-AEC7-E30A43919C39Q38171224-CC45304E-83A2-4EAC-A42F-03DEEDA8E0B8Q38750675-66297658-1476-4688-8F43-D7D82DC5D1E8Q38795520-0E7C50CB-AE3A-42CD-AD46-A23EE8F45DE7Q38877963-E1CA85CF-D6F3-4D5A-825B-A5F4C32EF58BQ38883322-33B71405-7CC2-4829-98E7-808C083871D8Q39014519-A46B00B8-89EE-4CDA-8B44-10294CB33755Q39556754-5FA34BC0-D5B8-4F44-9ADB-9FD19B521897Q40060114-DCA86033-6769-45C0-8B53-C29A72101FA2Q44110792-7A6E5736-B1C0-4DEE-8BD0-EA2428D8FF51Q45988106-84445F37-DEB5-4476-AF15-E044F512A370Q48263052-37443695-879D-40E1-B196-3E7EC3FFFDDCQ50936552-34E106EE-93A3-40EA-8AF4-02EAF7495533Q52668254-57EC9D37-8EF4-42E0-945C-3873A8916EC1Q55640363-7429DCD7-90AE-49EB-A751-99E40D8944D1Q90439258-8ABA5D8D-C2A5-48C9-89A7-7E611BD1D0F9Q90684189-E59C53F8-0502-461B-B0CD-DF949B6E3B50
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Muhammad Baghdadi
@ast
Muhammad Baghdadi
@en
Muhammad Baghdadi
@es
Muhammad Baghdadi
@nl
type
label
Muhammad Baghdadi
@ast
Muhammad Baghdadi
@en
Muhammad Baghdadi
@es
Muhammad Baghdadi
@nl
prefLabel
Muhammad Baghdadi
@ast
Muhammad Baghdadi
@en
Muhammad Baghdadi
@es
Muhammad Baghdadi
@nl
P106
P1153
54882982900
P31
P496
0000-0002-2347-8889